iodamide meglumine (Renovue-65, Renovue-DIP)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

Injection: 24% (300 mL), 65% (50 mL)

Monitor

  • observe for 30-60 minutes for immediate hypersensitivity reactions
  • resuscitative measures should be available prior to administration

More general terms

References

  1. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  2. 2.0 2.1 2.2 Deprecated Reference

Database